Loading...
Quizartinib for the treatment of FLT3/ITD acute myeloid leukemia
FLT3/ITD acute myeloid leukemia is a poor prognosis disease driven by a constitutively activated receptor tyrosine kinase, making it an obvious target for drug development. The development of clinically effective FLT3 inhibitors has been slow, in part because many are multi-targeted inhibitors that...
Saved in:
| Published in: | Future Oncol |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081740/ https://ncbi.nlm.nih.gov/pubmed/25145428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.14.105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|